The University of Chicago Header Logo

Connection

Wei-Jen Tang to Drug Evaluation, Preclinical

This is a "connection" page, showing publications Wei-Jen Tang has written about Drug Evaluation, Preclinical.
Connection Strength

0.331
  1. Discovery of a small molecule that inhibits the interaction of anthrax edema factor with its cellular activator, calmodulin. Chem Biol. 2004 Aug; 11(8):1139-46.
    View in: PubMed
    Score: 0.213
  2. Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nat Biotechnol. 2004 Jun; 22(6):717-23.
    View in: PubMed
    Score: 0.052
  3. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. Eur J Med Chem. 2019 Oct 01; 179:557-566.
    View in: PubMed
    Score: 0.037
  4. Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice. Nat Commun. 2015 Sep 23; 6:8250.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.